UsAgainstAlzheimer’s Applauds Inclusion of Paid Leave Policy in New Budget Reconciliation Legislation

Calls for the passage of universal paid family & medical leave

 

Washington, D.C. (September 10, 2021) – UsAgainstAlzheimer’s issued the following statement applauding Congressional leadership for including a universal, national paid family and medical leave policy in legislation released this week. If enacted into law, this would be an historic step forward in advancing economic and racial justice for family caregivers.

“The bill’s provision of twelve weeks of paid leave would help millions of Americans who are struggling to provide care for a family member living with dementia while balancing work, other family obligations and financial challenges. 

“The dementia caregiving crisis is especially severe for women and communities of color who are more likely to have caregiving responsibilities and who are at higher risk of dementia themselves. This potential disparate impact has been made clear by the COVID-19 pandemic, which has forced 16% of Latino and 13% of Black adults to leave the workforce to provide care for an adult family member.  This is not sustainable during a time of recovery for families or the economy.

“The proposal, recognizing the potential harm that can be done to vulnerable and marginalized communities, sets aside funding to specifically address these populations through culturally tailored outreach and research to identify and respond to access disparities and other challenges as they may arise.

“We urge Congress to take this important first step toward ensuring comprehensive paid family and medical leave policy, which would aid states and employers in offering this critical support to their workers and families navigating complex health challenges, such as dementia.”

###

About UsAgainstAlzheimer’s

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. We take on the toughest problems; bring all of “Us” together to break down barriers; advocate for research that will speed treatments to market; and drive changes that matter most to people living with the disease. We will not rest until brain-span equals lifespan - for everyone.